TrialBritish journal of clinical pharmacology2012

Single dose pharmacokinetics, pharmacodynamics, tolerability and safety of BAY 60-5521, a potent inhibitor of cholesteryl ester transfer protein.

Michael-Friedrich Boettcher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.